EUCTR2008-000094-37-DKActive, not recruitingNot Applicable
Effect of PTH(1-34)-treatment on fracture healing in vivo
Glostrup University Hospital0 sitesStarted: February 8, 2008Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •Acute new osteoporotic hip fracture or collum chirurgicum fracture
- •Age 50-85 years
- •Postmenopause
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Calcium metabolic disease other than osteoporosis
- •Diseases known to affect calcium homeostasis
- •Hypersensitivity to drug or other components of medication
- •Pre-existing hypercalcemia
- •Decreased kidney function
- •Increased alkaline phosphatase
- •Prior external radiation therapy or brachytherapy of the skeleton
- •Skeletal malignancies or bone metastases
- •Alcohol and/or drug abuse
- •Systemic treatment with corticosteroids within the last four weeks
- •Non-cooperating patients
- •Patients who do not speak and understand the Danish language
Investigators
Similar Trials
Withdrawn
Phase 2
Effect of PTH(1-34) Treatment on Fracture Healing in VivoShoulder FracturesTrochanteric FracturesNCT00741182Glostrup University Hospital, Copenhagen
Completed
Phase 1
Impact of Parathyroid Hormone (PTH) on Osseous CavityBone LossPeriodontitisNCT00277706University of Michigan40
Completed
Not Applicable
Early Effects of Parathyroid Hormone (PTH) on the Proximal FemurOsteoporosisNCT01309399Health Research, Inc.40
Active, not recruiting
Phase 1
Does parathyroid hormone enhance healing after spinal fusion?Decompression and fusion due to spinal stenosis in men and postmenopausal women. In this study we want to examine if Forsteo (teriparatide) improves bone healing (jugded by blinded investigators) and if this improves the function and decreases the pain at 7 weeks and 6 months.EUCTR2011-002917-12-SEDepartment of Orthopaedics IKE100
Completed
Phase 4
Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?Spinal StenosisNCT02090244University Hospital, Linkoeping34